The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

doi:10.1084/jem.167.2.353

This Article

	Full Text (PDF, 1599K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Harris, A. W.
	Articles by Adams, J. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Harris, A. W.
	Articles by Adams, J. M.


Social Bookmarking

	What's this?

ARTICLES

The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

AW Harris, CA Pinkert, M Crawford, WY Langdon, RL Brinster and JM Adams
Walter and Eliza Hall Institute of Medical Research, Victoria, Australia.

Mice transgenic for a c-myc gene driven by the IgH enhancer (E mu-myc) were shown to almost invariably develop lymphomas, 90% succumbing in the first 5 mo of life. The tumors typically presented as rapidly progressive lymphadenopathy with thymic involvement and were highly malignant by transplantation assay. Morphologically, they were lymphoblastic lymphomas, usually accompanied by lymphoid leukemia and granulocytosis, and were distinct from the tumors that arose much later in 37% of nontransgenic mice of the same (C57BL/6 x SJL)F2 genetic background. Cell-surface markers on 31 E mu-myc tumors identified 52% as pre-B lymphomas, 29% as mixed pre-B and B lymphomas, and 19% as B lymphomas. The tumors appeared to arise at random from a population of pre-B cells expanded by constitutive expression of the myc transgene. A majority of the animals initiated malignancy at the rate of 17% per week. The rate at which the cycling, benign pre-B cells spontaneously convert to malignancy was estimated to about 10(-10) per cell per generation. A transient leukocytosis identified in young E mu-myc mice was developed into a rapid assay for inheritance of the transgene.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Nepal, R. M., Tong, L., Kolaj, B., Edelmann, W., Martin, A. (2009). Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas. Proc. Natl. Acad. Sci. USA 106: 18698-18703 [Abstract] [Full Text]
Ho, L. H., Taylor, R., Dorstyn, L., Cakouros, D., Bouillet, P., Kumar, S. (2009). A tumor suppressor function for caspase-2. Proc. Natl. Acad. Sci. USA 106: 5336-5341 [Abstract] [Full Text]
Bolitho, P., Street, S. E. A., Westwood, J. A., Edelmann, W., MacGregor, D., Waring, P., Murray, W. K., Godfrey, D. I., Trapani, J. A., Johnstone, R. W., Smyth, M. J. (2009). Perforin-mediated suppression of B-cell lymphoma. Proc. Natl. Acad. Sci. USA 106: 2723-2728 [Abstract] [Full Text]
Mason, K. D., Vandenberg, C. J., Scott, C. L., Wei, A. H., Cory, S., Huang, D. C. S., Roberts, A. W. (2008). In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas. Proc. Natl. Acad. Sci. USA 105: 17961-17966 [Abstract] [Full Text]
Mori, S., Rempel, R. E., Chang, J. T., Yao, G., Lagoo, A. S., Potti, A., Bild, A., Nevins, J. R. (2008). Utilization of Pathway Signatures to Reveal Distinct Types of B Lymphoma in the E{micro}-myc Model and Human Diffuse Large B-Cell Lymphoma. Cancer Res. 68: 8525-8534 [Abstract] [Full Text]
Minard-Colin, V., Xiu, Y., Poe, J. C., Horikawa, M., Magro, C. M., Hamaguchi, Y., Haas, K. M., Tedder, T. F. (2008). Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage Fc{gamma}RI, Fc{gamma}RIII, and Fc{gamma}RIV. Blood 112: 1205-1213 [Abstract] [Full Text]
Jardin, F., Ruminy, P., Kerckaert, J.-P., Parmentier, F., Picquenot, J.-M., Quief, S., Villenet, C., Buchonnet, G., Tosi, M., Frebourg, T., Bastard, C., Tilly, H. (2008). Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas. haematol 93: 543-550 [Abstract] [Full Text]
Unni, A. M., Bondar, T., Medzhitov, R. (2008). Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance. Proc. Natl. Acad. Sci. USA 105: 1686-1691 [Abstract] [Full Text]
Habib, T., Park, H., Tsang, M., de Alboran, I. M., Nicks, A., Wilson, L., Knoepfler, P. S., Andrews, S., Rawlings, D. J., Eisenman, R. N., Iritani, B. M. (2007). Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. JCB 179: 717-731 [Abstract] [Full Text]
Kelly, P. N., Puthalakath, H., Adams, J. M., Strasser, A. (2007). Endogenous bcl-2 is not required for the development of E{micro}-myc induced B-cell lymphoma. Blood 109: 4907-4913 [Abstract] [Full Text]
Lenburg, M. E., Sinha, A., Faller, D. V., Denis, G. V. (2007). Tumor-specific and Proliferation-specific Gene Expression Typifies Murine Transgenic B Cell Lymphomagenesis. J. Biol. Chem. 282: 4803-4811 [Abstract] [Full Text]
Harrell, M. I., Iritani, B. M., Ruddell, A. (2007). Tumor-Induced Sentinel Lymph Node Lymphangiogenesis and Increased Lymph Flow Precede Melanoma Metastasis. Am. J. Pathol. 170: 774-786 [Abstract] [Full Text]
Kotani, A., Kakazu, N., Tsuruyama, T., Okazaki, I.-m., Muramatsu, M., Kinoshita, K., Nagaoka, H., Yabe, D., Honjo, T. (2007). Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice. Proc. Natl. Acad. Sci. USA 104: 1616-1620 [Abstract] [Full Text]
Bertwistle, D., Sherr, C. J. (2007). Regulation of the Arf tumor suppressor in E{micro}-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis. Blood 109: 792-794 [Abstract] [Full Text]
Wen, R., Chen, Y., Bai, L., Fu, G., Schuman, J., Dai, X., Zeng, H., Yang, C., Stephan, R. P., Cleveland, J. L., Wang, D. (2006). Essential Role of Phospholipase C{gamma}2 in Early B-Cell Development and Myc-Mediated Lymphomagenesis. Mol. Cell. Biol. 26: 9364-9376 [Abstract] [Full Text]
Smith, D. P., Bath, M. L., Metcalf, D., Harris, A. W., Cory, S. (2006). MYC levels govern hematopoietic tumor type and latency in transgenic mice. Blood 108: 653-661 [Abstract] [Full Text]
Talos, F., Petrenko, O., Mena, P., Moll, U. M. (2005). Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo. Cancer Res. 65: 9971-9981 [Abstract] [Full Text]
Yazawa, N., Hamaguchi, Y., Poe, J. C., Tedder, T. F. (2005). Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease. Proc. Natl. Acad. Sci. USA 102: 15178-15183 [Abstract] [Full Text]
Gururajan, M., Chui, R., Karuppannan, A. K., Ke, J., Jennings, C. D., Bondada, S. (2005). c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells. Blood 106: 1382-1391 [Abstract] [Full Text]
McCormick, D. L., Kavet, R. (2004). Animal Models for the Study of Childhood Leukemia: Considerations for Model Identification and Optimization to Identify Potential Risk Factors. International Journal of Toxicology 23: 149-161 [Abstract] [Full Text]
Egle, A., Harris, A. W., Bouillet, P., Cory, S. (2004). Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl. Acad. Sci. USA 101: 6164-6169 [Abstract] [Full Text]
Greenwald, R. J., Tumang, J. R., Sinha, A., Currier, N., Cardiff, R. D., Rothstein, T. L., Faller, D. V., Denis, G. V. (2004). E{micro}-BRD2 transgenic mice develop B-cell lymphoma and leukemia. Blood 103: 1475-1484 [Abstract] [Full Text]
Verschuren, E. W., Hodgson, J. G., Gray, J. W., Kogan, S., Jones, N., Evan, G. I. (2004). The Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis. Cancer Res. 64: 581-589 [Abstract] [Full Text]
Scott, C. L., Schuler, M., Marsden, V. S., Egle, A., Pellegrini, M., Nesic, D., Gerondakis, S., Nutt, S. L., Green, D. R., Strasser, A. (2004). Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation. JCB 164: 89-96 [Abstract] [Full Text]
Ruddell, A., Mezquita, P., Brandvold, K. A., Farr, A., Iritani, B. M. (2003). B Lymphocyte-Specific c-Myc Expression Stimulates Early and Functional Expansion of the Vasculature and Lymphatics during Lymphomagenesis. Am. J. Pathol. 163: 2233-2245 [Abstract] [Full Text]
Leider, N., Melamed, D. (2003). Differential c-Myc Responsiveness to B Cell Receptor Ligation in B Cell-Negative Selection. J. Immunol. 171: 2446-2452 [Abstract] [Full Text]
Houghton, P. J., Adamson, P. C., Blaney, S., Fine, H. A., Gorlick, R., Haber, M., Helman, L., Hirschfeld, S., Hollingshead, M. G., Israel, M. A., Lock, R. B., Maris, J. M., Merlino, G., Patterson, W., Reynolds, C. P., Shannon, K., Yu, A., Yu, J., Smith, M. A. (2002). Testing of New Agents in Childhood Cancer Preclinical Models: Meeting Summary. Clin. Cancer Res. 8: 3646-3657 [Abstract] [Full Text]
Eberhardy, S. R., Farnham, P. J. (2002). Myc Recruits P-TEFb to Mediate the Final Step in the Transcriptional Activation of the cad Promoter. J. Biol. Chem. 277: 40156-40162 [Abstract] [Full Text]
Eberhardy, S. R., Farnham, P. J. (2001). c-Myc Mediates Activation of the cad Promoter via a Post-RNA Polymerase II Recruitment Mechanism. J. Biol. Chem. 276: 48562-48571 [Abstract] [Full Text]
Eischen, C. M., Woo, D., Roussel, M. F., Cleveland, J. L. (2001). Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis. Mol. Cell. Biol. 21: 5063-5070 [Abstract] [Full Text]
SCHMITT, C.A., WALLACE-BRODEUR, R.R., ROSENTHAL, C.T., MCCURRACH, M.E., LOWE, S.W. (2000). DNA Damage Responses and Chemosensitivity in the E{micro}-myc Mouse Lymphoma Model. Cold Spring Harb Symp Quant Biol 65: 499-510 [Abstract]
Iritani, B. M., Eisenman, R. N. (1999). c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl. Acad. Sci. USA 96: 13180-13185 [Abstract] [Full Text]
Jacobs, J. J.L., Scheijen, B., Voncken, J.-W., Kieboom, K., Berns, A., van Lohuizen, M. (1999). Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13: 2678-2690 [Abstract] [Full Text]
Fanidi, A., Hancock, D. C., Littlewood, T. D. (1998). Suppression of c-Myc-Induced Apoptosis by the Epstein-Barr Virus Gene Product BHRF1. J. Virol. 72: 8392-8395 [Abstract] [Full Text]
Wasserman, R., Zeng, X.-X., Hardy, R. R. (1998). The Evolution of B Precursor Leukemia in the E�-ret Mouse. Blood 92: 273-282 [Abstract] [Full Text]
Cory, S., Strasser, A., Jacks, T., Corcoran, L.M., Metz, T., Harris, A.W., Adams, J.M. (1994). Enhanced Cell Survival and Tumorigenesis. Cold Spring Harb Symp Quant Biol 59: 365-375 [Abstract]
Adams, J., Cory, S (1991). Transgenic models of tumor development. Science 254: 1161-1167 [Abstract]
Eberhardy, S. R., D'Cunha, C. A., Farnham, P. J. (2000). Direct Examination of Histone Acetylation on Myc Target Genes Using Chromatin Immunoprecipitation. J. Biol. Chem. 275: 33798-33805 [Abstract] [Full Text]